Skip to main content

Decibel Therapeutics, Inc.

DBTXDelisted Sep 25, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001656536

Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in Decibel Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−1 vs. Q3 2022
Shares held
17.5M
−458.1K (−2.6%) vs. Q3 2022
Total value
$35.8M
−$26.2M (−42.3%) vs. Q3 2022
New holders
4
8 more added
Sold out
5
13 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 39 institutions
Q1 2021: 54 institutionsQ2 2021: 46 institutionsQ3 2021: 36 institutionsQ4 2021: 40 institutionsQ1 2022: 39 institutionsQ2 2022: 42 institutionsQ3 2022: 40 institutionsQ4 2022: 39 institutionsQ1 2023: 38 institutionsQ2 2023: 37 institutionsQ3 2023: 1 institutionQ4 2023: 1 institutionQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $35.8M
Q1 2021: $226.3MQ2 2021: $168.1MQ3 2021: $145.9MQ4 2021: $81.7MQ1 2022: $53.8MQ2 2022: $75.2MQ3 2022: $62.1MQ4 2022: $35.8MQ1 2023: $46.7MQ2 2023: $59.2MQ3 2023: $36.4KQ4 2023: $36.4KQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding DBTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20231$36.4K
Q3 20231$36.4K
Q2 202337$59.2M
Q1 202338$46.7M
Q4 202239$35.8M
Q3 202240$62.1M
Q2 202242$75.2M
Q1 202239$53.8M
Q4 202140$81.7M
Q3 202136$145.9M
Q2 202146$168.1M
Q1 202154$226.3M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q3 2022.

Institutions holding DBTX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC4,945,192$10.1M0.19%00.0%Unchanged
TRV GP III, LLC3,139,685$6.44M5.04%00.0%Unchanged
BlackRock Inc.1,805,108$3.70M0.00%−81,732−4.3%Reduced
Citadel Advisors LLC1,787,311$3.66M0.00%−21,675−1.2%Reduced
Alphabet Inc.1,636,258$3.35M0.19%00.0%Unchanged
Samsara BioCapital, LLC801,629$1.64M0.35%00.0%Unchanged
Vanguard Group Inc627,304$1.29M0.00%+4,367+0.7%Added
Bessemer Group Inc494,071$1.01M0.00%00.0%Unchanged
Millennium Management LLC488,783$1.00M0.00%+171,491+54.0%Added
Harvard Management Co Inc328,798$674.0K0.09%00.0%Unchanged
Newtyn Management, LLC270,000$553.5K0.11%−30,000−10.0%Reduced
Barclays PLC238,677$489.3K0.00%−800−0.3%Reduced
Bronte Capital Management Pty Ltd.159,405$327.0K0.04%−4,142−2.5%Reduced
JPMorgan Chase & Co130,572$267.0K0.00%−11,687−8.2%Reduced
Geode Capital Management, LLC115,567$236.0K0.00%+4,170+3.7%Added
Bridgeway Capital Management, LLC111,982$229.6K0.01%+50,000+80.7%Added
Point72 Asset Management, L.P.90,000$184.5K0.00%+90,000New
Renaissance Technologies LLC36,394$75.0K0.00%+4,094+12.7%Added
State Street Corp35,160$72.1K0.00%+18,000+104.9%Added
Dimensional Fund Advisors LP34,607$70.0K0.00%−6,734−16.3%Reduced
Bank of New York Mellon Corp27,732$56.9K0.00%00.0%Unchanged
Atlas Capital Advisors LLC25,000$51.3K0.01%00.0%Unchanged
Ergoteles LLC23,480$48.1K0.00%+23,480New
Federated Hermes, Inc.20,000$41.0K0.00%00.0%Unchanged
Marquette Asset Management, LLC19,783$40.6K0.01%00.0%Unchanged
Northern Trust Corp17,043$34.9K0.00%−1,000−5.5%Reduced
Neuberger Berman Group LLC16,261$33.3K0.00%−52,339−76.3%Reduced
Laurion Capital Management LP11,990$24.6K0.00%00.0%Unchanged
Morgan Stanley10,560$21.6K0.00%−1,512−12.5%Reduced
Charles Schwab Investment Management Inc10,345$21.2K0.00%00.0%Unchanged
Flagship Harbor Advisors, LLC10,113$20.7K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)9,978$20.0K0.00%−1,720−14.7%Reduced
Clear Street Markets LLC1,500$3.00K0.00%+1,500New
Cubist Systematic Strategies, LLC802$1.64K0.00%+802New
Bank of America Corp790$1.62K0.00%−4,474−85.0%Reduced
Simplex Trading, LLC711$1.00K0.00%−4−0.6%Reduced
Wells Fargo & Company88$1800.00%+2+2.3%Added
Financial Connections Group, Inc.300$00.00%00.0%Unchanged
Royal Bank of Canada222$00.00%+137+161.2%Added
EAM Investors, LLC0$00.00%−236,966−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−213,107−100.0%Sold out
UBS Oconnor LLC0$00.00%−157,745−100.0%Sold out
Citigroup Inc0$00.00%−291−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−233−100.0%Sold out